Press release
Alagille Syndrome Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Takeda, Mirum Pharmaceuticals, Albireo
The Key Alagille Syndrome Companies in the market include - Takeda, Mirum Pharmaceuticals, Albireo, and others.The Alagille Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Alagille Syndrome pipeline products will significantly revolutionize the Alagille Syndrome market dynamics.
DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Alagille Syndrome, historical and forecasted epidemiology as well as the Alagille Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Alagille Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Alagille Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alagille Syndrome Market Insights [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Alagille Syndrome Market Report:
*
The Alagille Syndrome market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In March 2025, Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced today that its partner, Takeda Pharmaceutical Company Limited, has obtained approval from the Japanese Ministry of Health, Labour, and Welfare for LIVMARLI Registered (maralixibat) oral solution to treat cholestatic pruritus in patients with Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC) in Japan.
*
In January 2025, Enrollment is continuing in a Phase 3 clinical trial aimed at assessing Mirum Pharmaceuticals' maralixibat for treatment-resistant itching (pruritus) linked to rare cholestatic conditions. Maralixibat, marketed as Livmarli in the U.S. and European Union, is approved for treating pruritus associated with Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC).
*
In September2024, Ipsen announced that the European Commission has granted exceptional approval for Kayfanda Registered (odevixibat) to treat cholestatic pruritus in patients with Alagille Syndrome (ALGS) aged 6 months and older. Kayfanda is a once-daily, non-systemic ileal bile acid transport (IBAT) inhibitor. Its active ingredient, odevixibat, reduces serum bile acids by blocking the ileal bile acid transporter.
*
DelveInsight's analysis estimates that the total prevalent cases of Alagille Syndrome (ALGS) across the 7MM were approximately 17,883 in 2023, with a projected increase throughout the forecast period (2024-2034). This growth is attributed to rising awareness and population expansion, leading to a higher prevalence of ALGS.
*
Germany reported the highest proportion of ALGS cases among the EU4 and the UK, while Spain had the lowest number of cases.
*
In 2023, the gender-specific cases of ALGS in the US were approximately 3,846 for males and 2,978 for females, with numbers anticipated to rise during the forecast period (2024-2034).
*
DelveInsight's experts analyzed the age-specific cases of ALGS, categorizing them into 0-0.5 years, 0.5-10 years, 11-20 years, and >20 years. In 2023, the highest number of cases (~4,436) was recorded in the 0.5-10 year age group in the US.
*
DelveInsight's estimates categorized the prevalence of ALGS based on its type into patients with chronic cholestasis and those without. In 2023, Japan reported a higher number of cases in patients with chronic cholestasis, with approximately 1,177 cases.
*
Key Alagille Syndrome Companies: Takeda, Mirum Pharmaceuticals, Albireo, and others
*
Key Alagille Syndrome Therapies: TAK-625, Maralixibat, Odevixibat, and others
*
The Alagille Syndrome epidemiology based on gender analyzed that Alagille Syndrome affects males and females in equal numbers
Alagille Syndrome Overview
Alagille Syndrome (ALGS) is a multisystem autosomal dominant disorder with a wide variety of clinical manifestations. It is also known as arteriohepatic dysplasia, Alagille-Watson syndrome, Watson-Miller syndrome or syndromic bile duct paucity.
Get a Free sample for the Alagille Syndrome Market Report
https://www.delveinsight.com/report-store/alagille-syndrome-market [https://www.delveinsight.com/report-store/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Alagille Syndrome Market
The dynamics of the Alagille Syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2020-2034.
"Of the emerging therapies, the most anticipated product to get launched in the near future includes Odevixibat (Albireo). Odevixibat have also received Orphan Designation."
Alagille Syndrome Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Alagille Syndrome Epidemiology Segmentation:
The Alagille Syndrome market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Alagille Syndrome
*
Prevalent Cases of Alagille Syndrome by severity
*
Gender-specific Prevalence of Alagille Syndrome
*
Diagnosed Cases of Episodic and Chronic Alagille Syndrome
Download the report to understand which factors are driving Alagille Syndrome epidemiology trends @ Alagille Syndrome Epidemiological Insights [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Alagille Syndrome Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alagille Syndrome market or expected to get launched during the study period. The analysis covers Alagille Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Alagille Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Alagille Syndrome Therapies and Key Companies
*
Odevixibat: Albireo, an Ipsen Company
*
TAK-625: Takeda
*
Maralixibat: Mirum Pharmaceuticals
To know more about Alagille Syndrome treatment, visit @ Alagille Syndrome Medications [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Alagille Syndrome Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Alagille Syndrome Companies: Takeda, Mirum Pharmaceuticals, Albireo, and others
*
Key Alagille Syndrome Therapies: TAK-625, Maralixibat, Odevixibat, and others
*
Alagille Syndrome Therapeutic Assessment: Alagille Syndrome current marketed and Alagille Syndrome emerging therapies
*
Alagille Syndrome Market Dynamics: Alagille Syndrome market drivers and Alagille Syndrome market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Alagille Syndrome Unmet Needs, KOL's views, Analyst's views, Alagille Syndrome Market Access and Reimbursement
Discover more about therapies set to grab major Alagille Syndrome market share @ Alagille Syndrome Treatment Landscape [https://www.delveinsight.com/sample-request/alagille-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Alagille Syndrome Market Report Introduction
2. Executive Summary for Alagille Syndrome
3. SWOT analysis of Alagille Syndrome
4. Alagille Syndrome Patient Share (%) Overview at a Glance
5. Alagille Syndrome Market Overview at a Glance
6. Alagille Syndrome Disease Background and Overview
7. Alagille Syndrome Epidemiology and Patient Population
8. Country-Specific Patient Population of Alagille Syndrome
9. Alagille Syndrome Current Treatment and Medical Practices
10. Alagille Syndrome Unmet Needs
11. Alagille Syndrome Emerging Therapies
12. Alagille Syndrome Market Outlook
13. Country-Wise Alagille Syndrome Market Analysis (2020-2034)
14. Alagille Syndrome Market Access and Reimbursement of Therapies
15. Alagille Syndrome Market Drivers
16. Alagille Syndrome Market Barriers
17. Alagille Syndrome Appendix
18. Alagille Syndrome Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=alagille-syndrome-market-growth-to-accelerate-in-forecast-period-20242034-delveinsight-analyzes-takeda-mirum-pharmaceuticals-albireo]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alagille Syndrome Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Takeda, Mirum Pharmaceuticals, Albireo here
News-ID: 3952022 • Views: …
More Releases from ABNewswire

Avanti Rides Debuts in Southern Florida, Transforming How Drivers and Passengers …
Miami, FL - Avanti Rides introduces a new chapter in ride-hailing by combining passenger safety, driver empowerment, and seamless technology into a single app. Designed for the evolving needs of both drivers and riders, Avanti is delivering smarter bookings, stronger protection, and unmatched flexibility.
Built for Drivers Who Want More Than Just Rides
Avanti Rides recognizes that drivers are the foundation of the platform and offers a range of benefits focused on…

UVS-IT Unveils Guide to Choosing the Best Managed IT Services in Atlanta
Hey there, Atlanta business warriors! Have you ever felt that picking the perfect Managed IT Service is a bit like choosing the ultimate wingman for your company's tech needs? Trust me, it's not just a matter of finding someone who looks good on paper. With technology increasingly steering the ship of our businesses, selecting a reliable Managed IT Service is becoming as crucial as that morning cup of coffee we…

3D-Engineering: How 3D Scanning Services Are Revolutionizing Modern Engineering …
Imagine being able to capture every nook and cranny of an object down to the most intricate detail. Sounds magical, right? That's the power of 3D scanning services [https://3d-engineering.net/engineering-services/3d-laser-scanning-services/] in today's engineering projects. Across industries, from automotive and construction to aerospace and healthcare, 3D scanning is transforming how things are measured, mapped, and made. Whether you're designing a new building or manufacturing precision components, 3D scanning takes you from the…

SLCLawyer: How a Separation Agreement Can Help Couples Save Thousands in Legal F …
Image: https://www.abnewswire.com/upload/2025/10/7d762be2535d9a3c2274975ea0a87869.jpg
When John and Mary decided to separate after 12 years of marriage, they thought they could handle it on their own. Money was tight, emotions were high, and the internet offered dozens of free and cheap separation agreement templates. They downloaded one, filled in the blanks, and signed it at the kitchen table.
At first, it seemed like a practical solution. They avoided paying lawyers, saved a few hundred dollars,…
More Releases for Alagille
Alagille Syndrome Market is Set to Experience a Revolutionary Growth
Alagille Syndrome market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Alagille Syndrome Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as…
Alagille Syndrome Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Alagille Syndrome Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Alagille Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alagille Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Alagille Syndrome Research.…
Alagille Syndrome Drugs Market Size 2032| Clinical Trials, Emerging Drugs, and C …
DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Alagille Syndrome, historical and forecasted epidemiology as well as the Alagille Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Alagille Syndrome market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Alagille Syndrome market size from…
Alagille Syndrome Market Analysis and Future Prospects for 2030
The world of the alagille syndrome market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment.…
Alagille Syndrome Market will exhibit a CAGR of around 6.62% by 2028
A worldwide Alagille Syndrome market report is the best to know the trends and opportunities in Healthcare industry. The forecast, analysis, evaluations and estimations carried out in this business report are all based upon the well established tools and techniques such as SWOT analysis and Porter's Five Forces analysis. These are the authentic tools used in market analysis on which businesses can trust confidently. The credible Alagille Syndrome market research…
Alagille Syndrome Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Alagille Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Alagille Syndrome, historical and forecasted epidemiology as well as the Alagille Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Alagille Syndrome market report provides current treatment practices, emerging drugs, Alagille Syndrome market share of the individual therapies, and current and forecasted Alagille Syndrome market size…